We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$354M
AUM Growth
+$42.6M
Cap. Flow
+$21.7M
Cap. Flow %
6.13%
Top 10 Hldgs %
34.16%
Holding
110
New
22
Increased
38
Reduced
31
Closed
18

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$9.24M
2
TMO icon
Thermo Fisher Scientific
TMO
+$9.06M
3
NSTG
NanoString Technologies, Inc.
NSTG
+$7.44M
4
XRAY icon
Dentsply Sirona
XRAY
+$6.15M
5
IRTC icon
iRhythm Holdings
IRTC
+$6.03M

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$8.25M
2
VWR
VWR Corporation
VWR
+$7.23M
3
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$5.2M
4
WMGI
Wright Medical Group Inc
WMGI
+$4.63M
5
HOLX
Hologic
HOLX
+$4.46M

Sector Composition

Rank Sector Weight
1 Healthcare 88.14%
2 Financials 2.42%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KITE
51
DELISTED
Kite Pharma, Inc.
KITE
$1.7M 0.48%
+16,400
New +$1.34M
PBYI icon
52
Puma Biotechnology
PBYI
$404M
$1.69M 0.48%
19,300
-10,300
-35% -$576K
RVTY icon
53
Revvity
RVTY
$12.6B
$1.66M 0.47%
24,400
+12,807
+110% +$796K
EHC icon
54
Encompass Health
EHC
$11B
$1.53M 0.43%
39,726
-98,549
-71% -$3.61M
ILMN icon
55
Illumina
ILMN
$31B
$1.53M 0.43%
9,046
-1,954
-18% -$338K
OFIX icon
56
Orthofix Medical
OFIX
$477M
$1.41M 0.4%
+30,400
New +$1.26M
RXDX
57
DELISTED
Ignyta, Inc.
RXDX
$1.37M 0.39%
+132,400
New +$1.08M
ENTL
58
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$1.3M 0.37%
+78,600
New +$1.09M
CI icon
59
Cigna
CI
$73.7B
$1.24M 0.35%
7,400
+4,400
+147% +$707K
FOLD
60
DELISTED
Amicus Therapeutics
FOLD
$1.2M 0.34%
118,800
-104,500
-47% -$841K
LH icon
61
Labcorp
LH
$25B
$1.11M 0.31%
8,395
-15,248
-64% -$1.87M
PTLA
62
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.08M 0.3%
+19,200
New +$769K
ZSAN
63
DELISTED
Zosano Pharma Corporation
ZSAN
$1.06M 0.3%
1,073
+220
+26% +$227K
RDUS
64
DELISTED
Radius Health, Inc.
RDUS
$1.06M 0.3%
+23,400
New +$894K
RNTX
65
Rein Therapeutics
RNTX
$63.1M
$993K 0.28%
+4,455
New +$978K
ZTS icon
66
Zoetis
ZTS
$32.4B
$967K 0.27%
15,500
-60,200
-80% -$3.56M
HUM icon
67
Humana
HUM
$43.7B
$962K 0.27%
4,000
+400
+11% +$90.6K
CNMD icon
68
CONMED
CNMD
$1.39B
$953K 0.27%
18,700
-8,400
-31% -$416K
BMRN icon
69
BioMarin Pharmaceuticals
BMRN
$11.6B
$845K 0.24%
9,300
+4,200
+82% +$382K
NKTR icon
70
Nektar Therapeutics
NKTR
$2.39B
$837K 0.24%
+2,853
New +$824K
HOLX
71
DELISTED
Hologic
HOLX
$836K 0.24%
18,429
-101,129
-85% -$4.46M
LLY icon
72
Eli Lilly
LLY
$1.02T
$790K 0.22%
9,600
-8,100
-46% -$661K
AKRX
73
DELISTED
Akorn Inc
AKRX
$751K 0.21%
22,400
-135,800
-86% -$4.42M
IMGN
74
DELISTED
Immunogen Inc
IMGN
$743K 0.21%
+104,500
New +$478K
ANIP icon
75
ANI Pharmaceuticals
ANIP
$1.8B
$730K 0.21%
+15,600
New +$753K
1 2
3
4 5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Endurant Capital Management held 110 positions worth $354M, up 14% from $311M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Endurant Capital Management deployed $21.7M of net new capital in Q2 2017, opening 22 new positions and adding to 38 existing holdings. Its largest new stake was Dentsply Sirona: 97,400 shares worth $6.32M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 86% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Hologic, an estimated $4.46M trimmed.

  • Endurant Capital Management's largest Q2 2017 buy was Dentsply Sirona: 97,400 shares worth $6.32M.
  • Endurant Capital Management added most to McKesson in Q2 2017, an estimated $9.24M increase.
  • Endurant Capital Management's biggest Q2 2017 reduction was Hologic, cutting an estimated $4.46M.
  • Endurant Capital Management fully exited CATALENT, INC. in Q2 2017, selling an estimated $8.25M.
  • Endurant Capital Management's ten largest holdings make up 34% of its $354M portfolio in Q2 2017.
  • Endurant Capital Management opened 22 new positions and closed 18 in Q2 2017.
  • Endurant Capital Management's portfolio value rose 14% quarter-over-quarter to $354M.

Based on Endurant Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.